MACM
MDCO

March Altus Capital Management’s Medicines Co MDCO Stock Holding History

March Altus Capital Management’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-22,077
Closed -$838K – 15
2015
Q3 		$838K Buy
+22,077
New +$775K 4.94% 7
2015
Q2 		– Sell
-34,744
Closed -$974K – 23
2015
Q1 		$974K Sell
34,744
-401,242
-92% -$11.3M 6.12% 10
2014
Q4 		$12.1M Buy
+435,986
New +$10.8M 5.51% 8
2014
Q1 		– Sell
-152,809
Closed -$5.9M – 37
2013
Q4 		$5.9M Buy
+152,809
New +$5.46M 1.79% 24

Other funds holding MDCO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

March Altus Capital Management's MDCO Position: Q4 2015 in Review

March Altus Capital Management sold out of Medicines Co (MDCO) in Q4 2015, closing a stake of 22,077 shares — an estimated $838K sold.

March Altus Capital Management first reported a position in MDCO in Q4 2013 and held it in 4 quarters. The position peaked at $12.1M in Q4 2014. 190 funds tracked by Wall St. Rank hold MDCO as of Q4 2015.

  • March Altus Capital Management reported no remaining Medicines Co position as of Q4 2015 after selling out during the quarter.
  • March Altus Capital Management sold 22,077 Medicines Co shares in Q4 2015, an estimated $838K.
  • March Altus Capital Management first reported a position in Medicines Co in Q4 2013 and held it in 4 quarters.
  • March Altus Capital Management's Medicines Co position peaked at $12.1M in Q4 2014.
  • 190 funds tracked by Wall St. Rank held Medicines Co as of Q4 2015.

Based on March Altus Capital Management's 13F filing for Q4 2015, filed 16 Feb 2016.